← Every company
Humacyte Inc SEC Filings
What Humacyte Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
HUMA overview →Filings on file
81
since Aug 4, 2020
Warning signs
4
latest Jul 31, 2026
Last results
Aug 12, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
Source: Humacyte Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on HUMA
Company overviewEverything on HUMA in one place, with the price.Insider tradingWhat HUMA's own officers and directors buy and sell.Executive payWhat HUMA awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in HUMA.Funds holding itWhich funds and ETFs hold HUMA, and how big a bet.LobbyingWhat HUMA spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on HUMA's account, and who they worked for.PatentsWhat HUMA is filing at the patent office.